Endocrine News talks with Kelly Gebo, MD, MPH, the chief medical and scientific officer of the NIH’s All of Us program, who explains why “one size does not fit all” when it comes to healthcare delivery and how this ambitious research program could be useful for both endocrine clinicians and scientists alike. A new research...
A home that routinely fails the “white glove test” may pose more of a health hazard than just constant sneezing. New research presented at ENDO 2019 shows that household dust could promote fat cell development in children. There’s a saying attributed to late interior designer Mario Buatta: “Dust is a protective coating for fine furniture.”...
The U.S. Food and Drug Administration has approved romosozumab-aqqg to treat osteoporosis in postmenopausal women at high risk of breaking a bone (fracture). These are women with a history of osteoporotic fracture or multiple risk factors for fracture, or those who have failed or are intolerant to other osteoporosis therapies. The drug will be marketed...
Genetic breakthroughs from three recent whole-exome sequencing studies of endometrial and endometriotic epithelial cells provided some unexpected findings linking endometriosis and ovarian cancer, according to a paper recently published in Endocrinology. The paper, by Serdar E. Bulun, MD, of the Feinberg School of Medicine at Northwestern University in Chicago, notes that while associations between endometriosis...
Exposure to tiny air pollution particles may lead to reduced sperm production, suggests new research in mice presented at ENDO 2019 in New Orleans, La. “Infertility rates are increasing around the world, and air pollution may be one of the main factors,” says lead researcher Elaine Maria Frade Costa, MD, PhD, of Sao Paulo University...
Denying preventive services increases medical costs, jeopardizes public health The Endocrine Society objects to the administration’s decision to severely restrict access to the Title X Family Planning Program, the nation’s only program for affordable birth control and reproductive care. The Title X program is essential in helping ensure that every person — regardless of income,...
Study finds oral side effects are uncommon and manageable Oral complications are rare in women taking medications for postmenopausal osteoporosis, according to a study published in The Journal of Clinical Endocrinology & Metabolism. An oral complication called osteonecrosis of the jaw (ONJ) is exposed bone in the jaw that is slow to heal (8 weeks...
A team of researchers has provided baseline characteristics for infants with atypical genital development born in the United States, according to a paper recently published in the Journal of the Endocrine Society. The researchers, led by Amy B. Wisniewski, PhD, of Cook’s Children’s Hospital in Fort Worth, Texas, write that little is known about the...
Endocrine News talks with Kelly Gebo, MD, MPH, the chief medical and scientific officer of the NIH’s All of Us program, who explains why “one size does not fit all” when it comes to healthcare delivery and how this ambitious research program could be useful for both endocrine clinicians and scientists alike. A new research...
